🇺🇸 GX-H9 in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 1
Most-reported reactions
- Blood Creatine Phosphokinase Increased — 1 report (100%)
Frequently asked questions
Is GX-H9 approved in United States?
GX-H9 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for GX-H9 in United States?
Genexine, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.